ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Fujifilm to begin Avigan trials in US with coronavirus patients

Phase 2 testing on new use of flu drug to enlist 50 subjects and go through June

Japan has said it will make Avigan available at no cost to countries that ask for it as a coronavirus remedy. (Photo by Takaki Kashiwabara)

TOKYO -- Fujifilm Holdings announced on Thursday that it will start U.S. clinical trials of Avigan, its flu-fighter that is said to be effective in treating the novel coronavirus, within the week. The trials, which will evaluate the safety and efficacy of the drug, will enlist about 50 COVID-19 patients.

In Japan, the company began clinical trials on Avigan at the end of March.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more